V. Casati et al., Tranexamic acid in off-pump coronary surgery: A preliminary, randomized, double-blind, placebo-controlled study, ANN THORAC, 72(2), 2001, pp. 470-475
Citations number
20
Categorie Soggetti
Cardiovascular & Respiratory Systems","Medical Research Diagnosis & Treatment
Background. We evaluated the hemostatic effects of tranexamic acid, a synth
etic antifibrinolytic drug, in patients undergoing beating-heart coronary s
urgery.
Methods. Forty consecutive patients were in a double-blind manner, prospect
ively randomized into two groups: 20 patients received tranexamic acid (bol
us of 1 g before skin incision, followed by continuous infusion of 400 mg/h
r during surgery), and 20 patients received saline. As primary outcomes, bl
eeding and allogeneic transfusions were considered. D-dimer and fibrinogen
plasma levels were also evaluated to monitor the activation of fibrinolysis
. Major postoperative thrombotic events, as a potential consequence of anti
fibrinolytic treatment, were recorded. Results. The treatment group had sig
nificantly lower postoperative bleeding (median [25th to 75th percentiles]:
400 mL [337 to 490 mL] vs 650 ml [550 to 862 mL], p < 0.0001), lower need
for allogeneic blood products (1,200 vs 5,300 mL, p < 0.001), and lower pos
toperative D-dimer plasma levels. No postoperative thrombotic complications
were observed in either group.
Conclusions. In this initial series of patients undergoing off-pump coronar
y surgery, tranexamic acid appears to be effective in reducing postoperativ
e bleeding and the need for allogeneic blood products. (C) 2001 by The Soci
ety of Thoracic Surgeons.